The changed accounting treatment with respect to pcp's makes it really difficult to see how recurring income and expenses (ie excluding development sales) are travelling. The cynic in me also wonders why a change was necessitated just as things started getting less than ebullient. And despite the changes, recurring incomes seems to be having a hard time exceeding recurring expenses.
Note numbers prior to Q3 FY18 have not been adjusted for changed accounting treatment. Numbers in local currency.
- Forums
- ASX - By Stock
- UOS
- Ann: Profit Result (1st Qtr 2019) UOA Development Bhd
Ann: Profit Result (1st Qtr 2019) UOA Development Bhd, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UOS (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.0¢ |
Change
0.010(1.82%) |
Mkt cap ! $186.7M |
Open | High | Low | Value | Volume |
55.0¢ | 56.0¢ | 55.0¢ | $35.35K | 64.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 54.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.0¢ | 3105 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.540 |
1 | 5716 | 0.525 |
1 | 5770 | 0.520 |
1 | 1000 | 0.500 |
1 | 1400 | 0.485 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 3105 | 1 |
0.565 | 120549 | 2 |
0.570 | 450000 | 2 |
0.575 | 50000 | 1 |
0.610 | 4134 | 1 |
Last trade - 15.48pm 21/10/2024 (20 minute delay) ? |
Featured News
UOS (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online